Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A morphologic variant of lung adenocarcinoma characterized by the presence of papillary structures.
Biomarker and diagnostic research for papillary lung adenocarcinoma has been reported in the published literature.
No clinical trials have been registered for papillary lung adenocarcinoma.
5 publications have been identified in PubMed for papillary lung adenocarcinoma. Research spans Case Report / Case Series (60%), Diagnostic / Biomarker (20%), and Basic Science / Preclinical (20%).
Mallik S (2026). [PMID: 42077225](https://pubmed.ncbi.nlm.nih.gov/42077225/). *Ann Thorac Med*. [Case Report / Case Series]
Tan CL (2025). [PMID: 41625814](https://pubmed.ncbi.nlm.nih.gov/41625814/). *Cureus*. [Case Report / Case Series]
Liu B (2025). [PMID: 40758603](https://pubmed.ncbi.nlm.nih.gov/40758603/). *Molecular pharmaceutics*. [Basic Science / Preclinical]
Trigueira AL (2025). [PMID: 40185379](https://pubmed.ncbi.nlm.nih.gov/40185379/). *Am J Med*. [Case Report / Case Series]
Meijer-Jorna LB (2025). [PMID: 40419275](https://pubmed.ncbi.nlm.nih.gov/40419275/). *Arch Pathol Lab Med*. [Diagnostic / Biomarker]
Data assembled from 2 of 12 sources · Last updated Sep 19, 2026, 5:49 PM UTC
AI-curated news mentioning papillary lung adenocarcinoma
Updated May 22, 2026
A retrospective cohort study investigates rare glandular tumors of the nasopharynx, focusing on papillary adenocarcinoma and salivary gland-type carcinomas. This research contributes to the understanding of these uncommon malignancies.